Patent · US Expired

Use of magnesium-pyridoxal-5'-phosphate-glutaminate for the prevention of diseases which result from vascular lesions

US5372999A · kind A · utility

27Cited by

1References

7Claims

0Family size

Assignee

Steigerwald Arzneimittelwerk GmbH · DE

Inventors

Werner Schneider · Erbach, DE
Britta Meyer · Baldham, DE
Erich F. Elstner · Gröbenzell, DE

Key dates

Filing date	Apr 2, 1993
Grant date	Dec 13, 1994
Priority date	—
Expiry date	Apr 2, 2013

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the use of magnesium-pyridoxal-5'-phosphate-glutaminate to prepare a pharmaceutical suitable for the reduction of LDL-bound peroxides and for the prophylaxis of vascular lesions resulting therefrom in the absence of hypercholesteraemia or hyperlipidaemia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.